Steroid Finished Tablets

Allergies
Tell your doctor if you have ever had any unusual or allergic reaction to medicines in this group or any other medicines. Also tell your health care professional if you have any other types of allergies, such as to foods dyes, preservatives, or animals. For non-prescription products, read the label or package ingredients carefully.

Pediatric
Anabolic steroids should be used with caution in pediatric patients. This medicine may cause children to stop growing or their bone growth to slow down. In addition, they may make male children develop too fast sexually and may cause male-like changes in female children.

Geriatric
When elderly male patients are treated with anabolic steroids, they may have an increased risk of enlarged prostate or cancer of the prostate.

Pregnancy
Anabolic steroids should not be used during pregnancy. They may cause the development of male features in the female fetus and premature growth and development of male features in the male fetus. Be sure you have discussed this with your doctor.

Breastfeeding
It is not known whether anabolic steroids pass into breast milk.

Drug Interactions
Although certain medicines should not be used together at all, in other cases two different medicines may be used together even if an interaction might occur. In these cases, your doctor may want to change the dose, or other precautions may be necessary. When you are taking any of these medicines, it is especially important that your healthcare professional know if you are taking any of the medicines listed below. The following interactions have been selected on the basis of their potential significance and are not necessarily all-inclusive.

Using medicines in this class with any of the following medicines is not recommended. Your doctor may decide not to treat you with a medication in this class or change some of the other medicines you take.

Using medicines in this class with any of the following medicines is usually not recommended, but may be required in some cases. If both medicines are prescribed together, your doctor may change the dose or how often you use one or both of the medicines.

The concept of the production rate of a steroid hormone was introduced to describe the rate at which the hormone enters the circulation de novo, regardless of its origin. Therefore, by definition, the production rate of a steroid hormone is equal to the glandular secretion rate of the hormone plus the secretion rates of any other steroids that are converted extraglandularly to the circulating hormone. In the absence of extraglandular sources of the circulating hormone, the production rate of the hormone is identical to its secretion rate. From the practical point of view, the secretion of a steroid hormone by an endocrine gland can be determined by catheterizing the vein draining the organ and demonstrating a higher concentration of the hormone in the venous effluent of the gland than in the peripheral blood. The concentration gradient (difference between the two concentrations) multiplied by the rate of blood flow from the gland yields a rough approximation of the secretion rate.

It has been that the physiologic concentration of a steroid hormone in the circulation is directly proportional to its production rate; therefore,
The MCR of a steroid hormone is defined as the volume of blood that is irreversibly cleared of the steroid per unit of time and is usually expressed in liters per day. It is measured by intravenously infusing the radioactive form (usually tritiated) of the steroid, either as a single dose or as a constant rate over a prolonged period (e.g., 2 hours). The radioactive steroid that is infused should have a high specific activity (radioactivity per unit mass), so that only a minute mass of the steroid is administered and the mass does not contribute significantly to the concentration of the endogenous hormone.

The single injection and constant infusion methods yield equivalent MCR for a particular steroid. In the single-dose method, the changes in the concentration of radioactivity (disintegrations per minute [dpm]) associated with the hormone are measured as a function of time. The concentrations of radioactivity are plotted against time, and the areas under the resulting curves are measured. The MCR is then calculated using the following equation: MCR = dose-injected (dpm) divided by area under the radioactivity concentration–time curve (dpm x h/ml).

Because the injected dose is expressed in dpm and the area under the curve as units of dpm per mL multiplied by hours, then the MCR units will be dpm ÷ (dpm × h)/mL.
which can be converted to liters per day. Similarly, if the labeled hormone is infused at a constant rate, a steady state of the radioactive hormone administered will be reached in blood, usually after 1 or 2 hours. A blood sample is taken at this time, and the MCR is calculated using the following equation: MCR = rate of infusion (dpm/h) divided by the concentration of radioactivity associated with the hormone in blood at steady state (dpm/mL).

Because PR ÷ C = MCR, the production rate of a steroid hormone can be readily determined once its MCR and concentration are known. The concentration of the steroid, C, can be measured by radioimmunoassay, whereas the MCR can be determined as described. The following example shows how the production rate of testosterone can be calculated. If the MCR of serum testosterone is found to be 700 L/day in a premenopausal woman and her serum testosterone concentration is measured as 0.35 μg/L, her testosterone production rate can be calculated from the equation, PR = MCR × C. By substituting the values for MCR and C, PR = 700 L/day × 0.35 μg/L = 245 μg/day. 

The risk and severity of prednisone side effects increase with the drug's dosage and how long you take it. The higher the dose, the higher the risk of side effects. The longer you are treated, the greater the risk of complications.

Prednisone is generally intended for short-term use to rein in inflammation and bring a disease under control. When that is achieved, the dose is gradually reduced until the treatment is finally stopped.

With some conditions, like autoimmune diseases, other drugs like biologics can then be prescribed to maintain control of the condition.

Choosing the Right Dose
Prednisone is also prescribed at the lowest possible dose to bring the disease under control. However, for some conditions, this is not possible, and higher doses are needed. If this is the case, your healthcare provider will weigh the benefits and risks of treatment.

If, for example, you are at risk of osteoporosis, your healthcare provider will need to monitor your condition and may prescribe supplements to protect the bones.

If you have certain conditions like open-angle glaucoma and must take prednisone, your healthcare provider may want you to see an eye healthcare provider. They can closely monitor for any increases in eye pressure or any worsening of glaucoma symptoms.

Stopping Prednisone Safely
Stopping prednisone abruptly is rarely a good idea, especially if you are taking more than 10 milligrams (mg) a day or have been on it for more than three weeks. This is because your body will have become accustomed to having the cortisol substitute in your system and no longer produce cortisol on its own.
Although prednisone is eliminated from the body rather quickly—usually within several days—it can take time before the body is able to produce enough cortisol to meet the body's needs.
Healthcare providers will usually taper gradually the dose so that the body has the chance to resume making cortisol on its own. Depending on your condition, how long you've been on treatment, and how large your dose was, the tapering can take days, weeks, or even months.